The long-term prognosis of 187 consecutive patients who received single aortic valve replacement using Smeloff-Cutter prosthesis was studied. Of the 163 patients who survived the operation, a long-term followup (up to eight years) was obtained in 153 patients (95%). A total of 34 patients (22%) died during the follow-up period. Including the hospital mortality, the actuarial su.vival rate of our patients with SmeloffCutter prosthesis was 0.69 after the fifth year and 0.611 after the eighth year of follow-up. This is similar to the actuarial survival rate of patients with Starr-Edwards prosthesis but it appears significantly better than the expected survival rate of symptomatic patients with aortic stenosis treated without surgery. Thus excluded.) Ten patients were excluded from the analysis because they had resection of the ascending aorta necessitating its grafting as well. Two of these ten patients died in hospital and an additional three patients died during the follow-up period. In addition, three other patients were excluded from the analysis because, in each case, surgery was undertaken as an emergency procedure in a terminal state. Two of these patients died in the hospital and the third patient died eight months later from congestive heart failure. angina, or dizziness or syncope on exertion. In eight patients symptoms were nonspecific, such as palpitation and easy fatiguability. In these patients, surgery was undertaken because of abnormal electrocardiogram (ECG) and chest Xray and hemodynamic abnormalities.
THE SELECTION OF PATIENTS for aortic
valve replacement and the choice of the type of artificial valve to be used should be based on figures of long-term survival and degree of symptomatic improvement for the valve in question. The long-term results of aortic valve replacement using the StarrEdwards prosthesis have been reported'`7 but comparable data on the Smeloff-Cutter prosthesis have not been published. The purpose of this communication is to report the late results of replacement of the aortic valve using the Smeloff-Cutter prosthesis in 187 consecutive patients. Patient Material and Methods A total of 200 patients had single aortic valve replacement performed by three cardiac surgeons* during the period 1966 to 1972, inclusive, at the University of Alberta Hospital. (Patients who had procedures on other valves or aortocoronary bypass surgery were excluded.) Ten patients were excluded from the analysis because they had resection of the ascending aorta necessitating its grafting as well. Two of these ten patients died in hospital and an additional three patients died during the follow-up period. In addition, three other patients were excluded from the analysis because, in each case, surgery was undertaken as an emergency procedure in a terminal state. Two of these patients died in the hospital and the third patient died eight months later from congestive heart failure. Table 1 summarizes the patient population and their symptoms before operation. Ninety-nine patients had clinical and hemodynamic findings of pure or dominant aortic stenosis (age 51 ± 10 yr), 31 patients had combined aortic stenosis and regurgitation (age 49 ± 12 yr) and 57 patients had pure or dominant aortic regurgitation (age 44 ± 12 yr). One hundred fifty-six patients were male; 31 patients were female. All patients except eight experienced one or more of the following symptoms: dyspnea on exertion, left ventricular failure (paroxysmal noctural dyspnea or pulmonary edema), angina, or dizziness or syncope on exertion. In eight patients symptoms were nonspecific, such as palpitation and easy fatiguability. In these patients, surgery was undertaken because of abnormal electrocardiogram (ECG) and chest Xray and hemodynamic abnormalities.
The findings of 12 lead ECGs are summarized in table 2 and heart size assessed by chest X-ray is summarized in table 3. On the whole, the cardiothoracic ratio was larger in patients with pure or dominant aortic regurgitation than in patients with aortic stenosis. The difference in distribution of the cardiothoracic ratio is significant (P < 0.01, x' = 25.63).
Left and right heart catheterization was carried out in all except three patients. In patients with dominant aortic stenosis, a systolic pressure gradient over 50 mm Hg was considered significant. In patients with pure or dominant aortic regurgitation, a significant degree of regurgitation was demonstrated by aortic root cineangiography. As a rule, the presence of an enlarged left ventricle on chest X-ray and an abnormal ECG were necessary conditions for operation in patients with aortic regurgitation.
None of the patients were denied surgery on the basis of severity of disease or the presence of high risk factors.
Detailed descriptions of the operative procedure have been published previously.8 B Briefly, the operation was carried out using temporary cardiopulmonary support with a Travenol disposable bubble oxygenator primed with buffered Ringer's lactate solution. The minimum flow rate was maintained at 40 ml/kg/min and the temperature of the perfusate was maintained between 30 and 37°C. Arterial blood gases and pH were monitored frequently during the operation. In 143 cases the operation was carried out with cor- Congestive heart failure, despite administration of medical treatment, caused death in four patients. In two of these, the murmur of aortic regurgitation was present on auscultation indicating some residual aortic regurgitation presumed to be due to a paravalvular leak. The remaining two patients had congestive heart failure prior to surgery.
At the time of the follow-up, a total of 20 patients (18%) had some symptoms: nine with residual effects of cerebrovascular accident, one with partial loss of vision of one eye secondary to a peripheral embolus, five with heart failure, four with hemolytic anemia and one patient with angina following unsuccessful aortocoronary bypass surgery. In addition four patients had mild to moderate degrees of paravalvular regurgitation at the time of postoperative catheterization but were asymptomatic.
Prosthetic endocarditis was diagnosed in three patients during the follow-up period. Two of them died subsequent to re-operation. The remaining one patient died from widespread embolization and aortic regurgitation. One additional patient had myocotic aneurysm of the aorta and died during re-operation.
Re-operation was necessary in a total of 14 patients (9%). Residual paravalvular aortic regurgitation was the indication in eight (including two patients with prosthetic endocarditis). Three of these eight patients died during the second operation. Three additional patients died during the follow-up period and the remaining two patients are alive. Four months after the initial operation one patient underwent an aortocoronary bypass procedure for stenosis of the main left coronary artery which was apparently caused by the coronary perfusion cannula used during the first operation. (The coronary arteriogram had been normal prior to the initial operation.) One other patient underwent coronary bypass surgery for obstructive coronary artery disease. Both of these patients are living. One patient subsequently had mitral valve replacement and is living, and another underwent mitral and tricuspid valve replacement unsuccessfully. One patient had re-operation because of recurrent embolism due to thrombosis of the prosthetic valve and is alive. The remaining one patient died during re-operation for myocotic aneurysm of the ascending aorta. Thus, six of the 14 patients who had reoperation are living (42%).
Discussion
Obviously, late survival following aortic valve replacement depends on many factors including myo- Thromboembolic complication depends not only on the type of prosthesis but also on the adequacy of anticoagulation. Among the living 120 patients at the time of follow-up, 99 patients were on anticoagulants and 19 patients were not. In our series, most of the serious thromboembolic complications occurred in patients who were not given anticoagulants. In a previous study from this institution,'1 a significantly higher incidence of thromboembolic complication was encountered in the patients who did not receive or who received inadequate anticoagulation compared to those who received adequate anticoagulation.
There were five (3.6%) sudden deaths for which autopsy examination was not performed. As far as we could ascertain, however, none of the deaths or serious complications could be ascribed to ball variance.
Comparison of hospital and late mortality between the groups of pure aortic stenosis (AS) and combined Circulation, Volume S2, December 1975 Presence of angina before surgery appears to increase the hospital mortality (table 8) . This is probably due to the fact that some patients with angina had significant coronary artery disease (which was not bypassed) and developed myocardial infarction during the perioperative period. The late mortality, however, did not differ between the two groups.
In table 9, the mortality was compared in the patients who did and did not experience left ventricular failure before the operation. The over-all hospital mortality was not different between the two groups. This is due to the fact that most hospital deaths were of a technical nature, and only three of 24 hospital deaths were directly due to poor left ventricular function (table 4). In the groups with AS and AS & AR, the late mortality was higher (31% vs 17%) in patients who had experienced left ventricular failure, although the difference is not statistically significant. The experience of the Mayo Clinic indicates that the longterm survival is influenced by the preoperative heart size. In our experience (table 10), the hospital mortality was lowest (8%) in patients with cardiothoracic ratio between 51% and 60% and it was higher in the group with cardiothoracic ratio of less than 50% (16%, P < 0.05) and over 60% (28%, P < 0.01). The late mortality was highest in the latter group (33% ) but the differences are not significant. Late survival following aortic valve replacement with different prostheses has previously been reported, 17 but the different methods adopted in presenting the survival data make any meaningful comparison difficult. Duvoisin and McGoon1 reported their longterm results with the original Starr-Edwards aortic prosthesis (non-cloth covered) by calculating survival rates based on the actual follow-up period of each patient, as we have done. Although our hospital mortality was higher (12.8%) than theirs (6%), the longterm survival was virtually identical. Bigelow et al. 4 have also reported favorable long-term results using Starr-Edwards prostheses, i.e., a late mortality of 15.5% in patients operated on between 1969-1972. However, their maximum follow-up was only four years. Since the advent of the original Starr-Edwards prosthesis, the cloth-covered metallic ball prosthesis has been introduced with the idea of reducing the incidence of ball variance and thromboembolic complications. Isom et al.5 using this prosthesis (model 2520) reported a much lower incidence of thromboembolic complication. However, their follow-up period was shorter, i.e., up to 57 months compared to our eight years, and their late mortality (21%) was similar to ours (22%).
Ross12 and Angell et al. 13 have reported encouraging results showing a lower incidence of thromboembolic complications using homograft but the incidence of aortic regurgitation is higher with biological valves and the long-term durability of the biological valve has yet to be confirmed.
Retrospective analyses of prognosis in patients with aortic stenosis4-" agree that the appearance of angina, syncope or pre-syncope, or heart failure is an indication of poor prognosis. Using data based on several autopsy studies, Ross and Braunwald19 es- The prognosis of symptomatic patients with aortic regurgitation is less well documented but it should be similar to that of the patients with aortic stenosis.2 22 Therefore, our experience as well as that of the Mayo Clinic suggests that aortic valve replacement in patients with these symptoms (angina, syncope or presyncope, or heart failure) can prolong life expectancy.
However, the same conclusion cannot be drawn in asymptomatic patients or patients with dyspnea only on strenuous exertion, as the natural history of such patients is unknown and is expected to be better than in those with the triad of symptoms. Recently, Rappaport20 pointed out that the medically treated prognosis is better in aortic regurgitation (75% survival in 5 years) than in aortic stenosis (38% survival in 5 years). Segal et al.23 also pointed out that the average Although the five year mortality in this group was only 30%, an additional 50% of patients developed heart failure or angina during the same period. Our data (table 11) suggest that surgery before the appearance of angina, syncope or left ventricular failure does not necessarily improve the hospital or late mortality. Thus, prophylactic surgery appears unjustifiable. However, the surgery should be undertaken without delay once symptoms of angina, syncope or left ventricular failure appear and before the appearance of gross cardiac enlargement (cardiothoracic ratio over 60%), since the result of surgery is poor in such patients.
